Duloxetine Capsule, Delayed Release
Product Images NDC 71205-445

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 71205-445). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-445-60 (Duloxetine 30mg 100s)

71205-445-60 (Duloxetine 30mg 100s)
Duloxetine 30mg is a prescription medication dispensed in a bottle containing 60 DR capsules. Each capsule consists of 33.7 mg of duloxetine hydrochloride equivalent to 30 mg of duloxetine. The medication is imprinted with "30mg" and "Dulox" on the cap with a white body and a blue-colored cap. The product ID is QD044560 and is manufactured by Alkem Laboratories Ltd in Mumbai, India. The medication guide must be distributed to every patient receiving the medication. It is advised to store the medication at 25°C, and keep it out of reach of children. The barcode and NDC are 71205-445-60 and 7120544560, respectively. It is distributed by Proficient Rx LP, located in Thousard Oaks, CA, and contains lot #00000 with an expiration date of 00/00/00.*
FDA Label Image

Duloxetine-fig3 (Duloxetine Fig3)

FDA Label Image

Duloxetine-fig4 (Duloxetine Fig4)

FDA Label Image

Duloxetine-fig7 (Duloxetine Fig7)

Duloxetine-fig7 (Duloxetine Fig7)
This appears to be a chart or graph showing the percentage of patients who improved in pain levels after receiving either a placebo or a medication called Didoreine (administered once) at a certain dosage. The chart includes percentages ranging from 0-100 for different levels of pain improvement. However, without more context or a clearer image, it is difficult to provide a more specific description.*
FDA Label Image

Duloxetine-fig8 (Duloxetine Fig8)

Duloxetine-fig8 (Duloxetine Fig8)
The text shows a chart displaying the percentage of patients improved with a scale ranging from 0% to 100%. The chart is measuring the percent improvement in pain from baseline using the BOCF method. The values in the chart range from 60% to 100%.*
FDA Label Image

Duloxetine-fig9 (Duloxetine Fig9)

FDA Label Image

Duloxetine-figure1 (Duloxetine Figure1)

Duloxetine-figure1 (Duloxetine Figure1)
This is a graph showing the proportion of patients with relapse while receiving treatment with a placebo or duloxetine. The X-axis represents the time from randomization to relapse in days, while the Y-axis shows the proportion of patients with relapse (ranging from 0 to 10%). The graph suggests that duloxetine may be more effective than a placebo in reducing the risk of relapse over time.*
FDA Label Image

Duloxetine-figure2 (Duloxetine Figure2)

FDA Label Image

Duloxetine-structure (Duloxetine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.